DxS extends EGFR license with Genzyme Genetics
DxS Ltd has expanded its license with Genzyme Genetics, a business unit of Genzyme Corporation, for epidermal growth factor receptor (EGFR) to include the United States and Canada.
Read MorePosted by Clinical Lab Products | Jan 5, 2009 | Cancer, Miscellaneous |
DxS Ltd has expanded its license with Genzyme Genetics, a business unit of Genzyme Corporation, for epidermal growth factor receptor (EGFR) to include the United States and Canada.
Read MorePosted by Clinical Lab Products | Dec 30, 2008 | Sexually Transmitted Diseases |
The U.S. Food and Drug Administration approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence of two divergent types of HIV in donated blood plasma and tissue.
Read MorePosted by Clinical Lab Products | Dec 17, 2008 | Cancer, Miscellaneous |
CombiMatrix Corporation has announced the introduction of the ProScan, which complements the company’s growing portfolio of array-based diagnostic tests.
Read MorePosted by Clinical Lab Products | Nov 11, 2008 | Miscellaneous |
PGxHealth has announced the launch of its new genetic test for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), an inherited and often fatal heart condition.
Read MorePosted by Clinical Lab Products | Nov 7, 2008 | Cancer, Flow Cytometry, Flow Cytometry Instruments |
BD FACSCanto II For routine HIV/AIDS monitoring The BD FACSCanto™ II flow cytometry system from BD Biosciences, Franklin Lakes, NJ, offers clinical laboratories an FDA-cleared cell analyzer for in vitro diagnostic (IVD) use. This new be
Read More